Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis
Authors:
- Inês ChoraICInês Chora
- Eloisa RomanoEREloisa Romano
- Mirko ManettiMirko Manetti
- Celestina MazzottaCMCelestina Mazzotta
- Raquel CostaRaquel Costa
- Vera MachadoVMVera Machado
- Alice CortezACAlice Cortez
- Cosimo BruniCBCosimo Bruni
- Gemma LepriGLGemma Lepri
- Serena GuiducciSGSerena Guiducci
- Amato De PaulisAPAmato De Paulis
- Raquel SoaresRaquel Soares
- 15 May 2017
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 44 (8) , 1190-1197
Abstract
Objective.: To investigate whether patients with a very early diagnosis of systemic sclerosis (VEDOSS) may already present circulating markers and in vitro signs of microvascular dysfunction.Methods.: Serum samples were obtained from 55 patients with systemic sclerosis (SSc), 25 patients with VEDOSS, and 55 matched healthy controls (HC). Serum levels of pan-vascular endothelial growth factor (VEGF) and soluble neuropilin-1 (sNRP-1) were measured by ELISA. Human dermal microvascular endothelial cells (H-MVEC) were cultured and stimulated with SSc, VEDOSS, and HC sera. Protein expression of NRP-1 was analyzed by Western blotting, cell proliferation by 5′-bromodeoxyuridine assay, migration capacity by wound-healing assay, and capillary-like tube formation by Matrigel assay.Results.: Serum levels of pan-VEGF were increased in patients with VEDOSS and SSc versus HC (p = 0.05 and p = 0.003, respectively). Serum levels of sNRP-1 were significantly reduced in patients with VEDOSS and SSc compared with controls (p = 0.012 and p = 0.027, respectively). NRP-1 expression was decreased in H-MVEC stimulated with VEDOSS sera (p < 0.001 vs HC). Proliferation was reduced in H-MVEC stimulated either with VEDOSS or SSc sera in comparison with HC sera (p = 0.015 and p = 0.043, respectively). Wound healing was compromised in H-MVEC stimulated with VEDOSS and SSc sera versus HC sera (p < 0.01 for both). Capillarogenesis was decreased in H-MVEC stimulated with VEDOSS sera (p < 0.01) and SSc sera (p < 0.001) compared with cells stimulated with HC sera.Conclusion.: Similar to patients with SSc, patients with VEDOSS already present biological signs of endothelial dysfunction. Our data demonstrate that VEDOSS sera significantly modify endothelial cell behavior and impair the angiogenic potential of the microvascular system.Keywords
This publication has 24 references indexed in Scilit:
- Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosisAnnals of the Rheumatic Diseases, 2016
- Raynaud's phenomenon: From molecular pathogenesis to therapyAutoimmunity Reviews, 2014
- Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cellsArthritis Research & Therapy, 2013
- Review: Evidence That Systemic Sclerosis Is a Vascular DiseaseArthritis & Rheumatism, 2013
- Differential expression of junctional adhesion molecules in different stages of systemic sclerosisArthritis & Rheumatism, 2012
- Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damageAnnals of the Rheumatic Diseases, 2012
- Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary dataRheumatology, 2011
- Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesisJournal of Cellular and Molecular Medicine, 2010
- Biomarkers in Systemic SclerosisBiomarkers in Medicine, 2010
- Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosisBritish Journal of Dermatology, 2009